Literature DB >> 1882114

Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis.

L P Ormerod1, R J Prescott.   

Abstract

The inter-relationships between relapse, treatment regimen and compliance in 1009 patients treated for tuberculosis between 1978 and 1987 are reported. Multiple linear logistic regression using relapse as the dependent variable was used because of the complex relationships between treatment, compliance, age and calendar year of treatment. Compliance (P less than 0.0001) was the major determinant of relapse, but age (P = 0.047) was also significantly associated. Relapse was not related to sex, site of disease, ethnic group or the presence of multiple disease sites. Although the regimen given, the total duration of treatment and treatment with or without pyrazinamide were not statistically associated with relapse, pyrazinamide containing regimens were associated with better compliance. Compliance was best in those aged 60 years and over and worst in those aged 15-29 years. Some of the non-compliance leading to relapse was only uncovered by close Health Visitor surveillance and not by the physician supervising treatment, emphasizing the important role of field staff in patient follow-up.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1882114     DOI: 10.1016/s0954-6111(06)80087-9

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  15 in total

1.  Hepatotoxicity of antituberculosis drugs.

Authors:  L P Ormerod; C Skinner; J Wales
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

Review 2.  Tuberculosis in the UK, 1994: current issues and future trends.

Authors:  L P Ormerod; R J Shaw; D M Mitchell
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

3.  Treatment and recurrence on re-treatment tuberculosis patients: a randomized clinical trial and 7-year perspective cohort study in China.

Authors:  Jian Du; Le Zhang; Yan Ma; X-Y Chen; Q-P Ge; X-Z Tian; Weiwei Gao; Zhongwei Jia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-05       Impact factor: 3.267

4.  Monitoring treatment of patients with pulmonary tuberculosis: can PCR be applied?

Authors:  V O Thomsen; A Kok-Jensen; M Buser; S Philippi-Schulz; H J Burkardt
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

5.  The challenge of re-treatment pulmonary tuberculosis at two teaching and referral hospitals in Uganda.

Authors:  Norbert Anyama; Simon Sseguya; Alphonse Okwera; Wael A El-Naggar; Fred Mpagi; Erisa Owino
Journal:  Afr Health Sci       Date:  2007-09       Impact factor: 0.927

6.  Illness costs to households are a key barrier to access diagnostic and treatment services for tuberculosis in Tajikistan.

Authors:  Raffael Ayé; Kaspar Wyss; Hanifa Abdualimova; Sadullo Saidaliev
Journal:  BMC Res Notes       Date:  2010-12-20

7.  DOTS for TB relapse in India: A systematic review.

Authors:  Gulrez Shah Azhar
Journal:  Lung India       Date:  2012-04

Review 8.  Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment.

Authors:  Qin Liu; Katharine Abba; Marissa M Alejandria; David Sinclair; Vincent M Balanag; Mary Ann D Lansang
Journal:  Cochrane Database Syst Rev       Date:  2014-11-18

9.  Smoking increases the risk of relapse after successful tuberculosis treatment.

Authors:  Joanna d'Arc Lyra Batista; Maria de Fátima Pessoa Militão de Albuquerque; Ricardo Arraes de Alencar Ximenes; Laura Cunha Rodrigues
Journal:  Int J Epidemiol       Date:  2008-06-13       Impact factor: 7.196

10.  SMS reminders to improve the tuberculosis cure rate in developing countries (TB-SMS Cameroon): a protocol of a randomised control study.

Authors:  Georges Bediang; Beat Stoll; Nadia Elia; Jean-Louis Abena; Désiré Nolna; Philippe Chastonay; Antoine Geissbuhler
Journal:  Trials       Date:  2014-01-24       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.